Explore Clinical Trials That Could Benefit You

Our site is currently enrolling for studies focused on critical health conditions. Participating in a clinical trial gives you access to cutting-edge treatments and contributes to medical advancements.

Sort By Condition

Sort By Location

Type 2 Diabetes

Location(s): Rovia Jacksonville – Southside (ECIR Site)

Prolongation of GLP-1 Adherence when using Continuous Glucose Monitoring

The primary purpose of this study is to utilize the FSL3 to help prolong the length of time people with diabetes maintain adherence to GLP-1 and GIP/GLP-1 antagonists. Subjects with type 2 diabetes who are newly beginning glucagon-like peptide 1 (GLP-1) and dual gastric inhibitory polypeptide/glucagon-like peptide 1 (GIP/GLP-1) agonist therapy will be assigned to use either the FSL3 or their existing Standard of Care (SOC) device to manage their type 2 diabetes. Effectiveness will be characterized by assessing the length of time subjects in each group remain on a GLP-1 or GLP-1/GIP combination drug.

Obesity, Type 2 Diabetes

Location(s): Rovia Canton (ECIR Site), Rovia Jacksonville – Southside (ECIR Site)

A Phase II Randomised, Doubleblind, Placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD6234 in participants living with overweight or obesity with Type 2 Diabetes who are on a stable dose of GLP-1 Receptor Agonist

We are doing this study to learn more about how safe the study drug AZD6234 is and how it affects your medical condition of overweight or obesity with type 2 diabetes when you are given the study drug AZD6234 along with a specific therapy called glucagon like peptide-1 receptor agonist (GLP-1 RA). Additional aims of the study are to better understand overweight or obesity with type 2 diabetes.

Amylin is a hormone that plays an important role in body weight management. The study drug AZD6234 can mimic amylin’s effects in the body and may aid in weight management, potentially helping with weight management and type 2 diabetes.

Type 2 Diabetes

Location(s): Rovia Lake City (ECIR Site)

Continuous glucosemonitoring (CGM) in people with type 2 diabetes not on insulin: The CONNECT Study

The purpose of this research is to find out how well using Continuous Glucose Monitoring (CGM) works to improve glucose control compared to routine care (RC) in people with type 2 diabetes not taking insulin. Routine care for a person with type 2 diabetes is typically to check blood glucose by fingerstick at certain times rather than using a CGM. Comparing CGM and routine care is experimental.

Frequently Asked Questions

We understand that enrolling in a clinical trial can raise many questions. How long will the trial last? Are there costs involved? What happens if the treatment doesn’t work for me? Our comprehensive FAQ section is here to address these concerns and more, empowering you with the knowledge you need to make an informed decision. Our goal is to provide answers with empathy and honesty, ensuring you feel supported at every stage of your trial participation. For further details or specific concerns, Read More FAQs to explore all the insights available.

Headquarters
3550 University Blvd South, Suite #101
Jacksonville, FL 32216

Tel: (904) 854-1354
Fax: (904) 854-1355